SBK-001

N/A

Report date: 2026/05/14 20:00:28
NME

Base Information

Drug NameSBK-001
Drug Alias NameSBK-001
ClassificationSmall molecules
Mechanisms of ActionAngiotensin-converting enzyme 2 inhibitors
TargetsAngiotensin-converting enzyme 2
Therapy Area/IndicationsCoughAcute Lung InjuryRespiratory Tract Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesChengdu Shibeikang Biomedical Technology Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesChengdu Shibeikang Biomedical Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsCoughAcute Lung InjuryRespiratory Tract Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A